最新公告:

  没有公告

您现在的位置: 心灵之窗-眼科医生网 >> 眼科常识 >> 第17届全国会 >> 正文
专题栏目
更多内容
相关文章
更多内容
Implication of the miR-184 and miR-204 Competitive RNA Network in Control of Mouse Secondary Cataracts           ★★★
Implication of the miR-184 and miR-204 Competitive RNA Network in Control of Mouse Secondary Cataracts
作者:黄钰森 文章来源:山东省眼科研究所 点击数:265 更新时间:2012/9/13

The high recurrence rate of secondary cataract is caused by the autogenous differentiation activity of residual lens epithelial cells following extra-capsular lens removal. The objective of this study was to identify expression of miRNAs utilizing an established mouse secondary cataract surgery model. Accordingly, cataract surgery-associated changes in expression patterns of 55 miRNAs were detected by microarray analysis. To further study the potential cataract counter-regulative effect of miRNAs, a lens capsular bag in vitro model was employed. Correspondingly, selective miRNA manipulation by antimiR-184 and premiR-204 was able to attenuate cataract-associated cell proliferation and signs of endothelial to mesenchymal transition such as á-SMA expression. In addition, premiR-204 was able to attenuate cataract-associated target gene expression of the transcription factor Meis2. Examination of miRNA target binding sites for miR-184 and miR-204 revealed an extensive range of predicted target mRNA sequences that were also target to a complex network of other cataract-associated miRNAs with possible opposing function. In summary, the identification of the cataractspecific miRNA expression pattern together with the observed in vitro attenuation of cataract characteristic appearance by manipulation of miR-184 and miR-204 expression suggest that secondary cataract in mice is controlled by a miR-184 and miR-204 competitive RNA network.

会议投稿录入:毛进    责任编辑:毛进 
  • 上一篇会议投稿:

  • 下一篇会议投稿:
  • 【字体: 】【发表评论】【加入收藏】【告诉好友】【打印此文】【关闭窗口
      网友评论:(只显示最新10条。评论内容只代表网友观点,与本站立场无关!)

    | 设为首页 | 加入收藏 | 联系站长 | 友情链接 | 版权申明 |
    眼科医生网 眼科医生网版权所有 @ 1998-2012
    部分文章和资源来源于网络,如果侵犯了您的版权,请指出! 站长:毛进
    信息产业部备案
    *京ICP备18030162号